The Latest Breaking News from ANI Pharmaceuticals

3 Biotech Stocks to Buy for Investor Security

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, and technological breakthroughs. Therefore, fundamentally strong biotech stocks ANI Pharmaceuticals (ANIP), Vanda Pharmaceuticals (VNDA) and Corcept Therapeutics (CORT) might be ideal additions to your portfolio. Read on.

StockNews.com · Feb 1, 2024

ANI Pharmaceuticals's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q1, ANI Pharmaceuticals's (NASDAQ:ANIP) reported sales totaled $64.48 million. Despite a 16.6% increase in earnings, the company posted a loss of $20.13 million.

Benzinga · Jun 8, 2022

ANI Pharmaceuticals: Q1 Earnings Insights

  ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Benzinga · May 10, 2022

ANI Pharmaceuticals's Earnings Outlook

ANI Pharmaceuticals (NASDAQ:ANIP) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts estimate that ANI Pharmaceuticals will report an earnings per share (EPS) of $0.74.

Benzinga · Mar 14, 2022